Trius Therapeutics Market Cap:
382.02M for May 17, 2013Trius Therapeutics Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 382.02M |
| May 16, 2013 | 377.23M |
| May 15, 2013 | 398.77M |
| May 14, 2013 | 390.16M |
| May 13, 2013 | 360.48M |
| May 10, 2013 | 359.04M |
| May 9, 2013 | 316.43M |
| May 8, 2013 | 321.70M |
| May 7, 2013 | 315.00M |
| May 6, 2013 | 323.14M |
| May 3, 2013 | 311.17M |
| May 2, 2013 | 309.25M |
| May 1, 2013 | 305.90M |
| April 30, 2013 | 333.64M |
| April 29, 2013 | 334.36M |
| April 26, 2013 | 335.56M |
| April 25, 2013 | 336.03M |
| April 24, 2013 | 335.56M |
| April 23, 2013 | 337.47M |
| April 22, 2013 | 313.06M |
| April 19, 2013 | 304.92M |
| April 18, 2013 | 300.61M |
| April 17, 2013 | 295.35M |
| April 16, 2013 | 298.22M |
| April 15, 2013 | 298.70M |
| April 12, 2013 | 305.40M |
| April 11, 2013 | 305.40M |
| April 10, 2013 | 310.66M |
| April 9, 2013 | 311.14M |
| April 8, 2013 | 298.22M |
| April 5, 2013 | 310.19M |
| April 4, 2013 | 301.57M |
| April 3, 2013 | 311.62M |
| April 2, 2013 | 331.25M |
| April 1, 2013 | 322.63M |
| March 28, 2013 | 327.32M |
| March 27, 2013 | 332.59M |
| March 26, 2013 | 334.98M |
| March 25, 2013 | 332.59M |
| March 22, 2013 | 334.50M |
| March 21, 2013 | 325.89M |
| March 20, 2013 | 325.89M |
| March 19, 2013 | 318.23M |
| March 18, 2013 | 324.93M |
| March 15, 2013 | 323.49M |
| March 14, 2013 | 329.72M |
| March 13, 2013 | 320.62M |
| March 12, 2013 | 297.17M |
| March 11, 2013 | 297.17M |
| March 8, 2013 | 297.65M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
TSRX Market Cap Benchmarks
| Companies | |
|---|---|
| Genomic Health | 1.126B |
| Acorda Therapeutics | 1.327B |
| Exelixis | 836.30M |
TSRX Market Cap Rankings
| Overall |
62nd percentile 2848 of 7593 |
| Sector |
59th percentile 265 of 650 in Healthcare |
| Industry |
52nd percentile 29 of 61 in Diagnostics & Research |
TSRX Market Cap Range, Past 5 Years
| Minimum | 71.22M | Dec 6 2010 |
| Maximum | 398.77M | May 15 2013 |
| Average | 182.58M |
TSRX News
Street Insider May 13